We expect prices to continue to decline. Leverage helps on the way up and it hurts on the day down. Boston Scientific recognizes it and that's why they want Guidant. |
When you have a look at the potential liability they have in infringement cases, you basically could save multiple billions of dollars. |
While it could be a knock-out blow, at what point are we overpaying? I think we could be getting close to that point based on the cardiac rhythm business. |
While Johnson & Johnson has the clear technology lead, the risk they run is in setting the price. If the price is favorable, doctors will reward them when new products come to market. |
You can't just sit back on your laurels. You have to constantly innovate. |